Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
William A Weiss
Affiliation
University of California san francisco
ORCID
Career Start Year
1985
Papers
213
H Index
69
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36264168
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.
Cancer Res
2023
36214645
Wnt Signaling in the Phenotype and Function of Tumor-Associated Macrophages.
Cancer Res
2023
36264168
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.
Cancer Res
2023
35716369
Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning.
Neuro Oncol
2023
37577529
Hedgehog target genes regulate lipid metabolism to drive basal cell carcinoma and medulloblastoma.
Res Sq
2023
36765089
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.
Nat Commun
2023
37236975
Diagnostic yield of pediatric and prenatal exome sequencing in a diverse population.
NPJ Genom Med
2023
37577529
Hedgehog target genes regulate lipid metabolism to drive basal cell carcinoma and medulloblastoma.
Res Sq
2023
35716369
Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning.
Neuro Oncol
2023
37236975
Diagnostic yield of pediatric and prenatal exome sequencing in a diverse population.
NPJ Genom Med
2023
36765089
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.
Nat Commun
2023
36214645
Wnt Signaling in the Phenotype and Function of Tumor-Associated Macrophages.
Cancer Res
2023
35027753
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
Nat Med
2022
36112789
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.
Cancer Res
2022
35972367
Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies.
CRISPR J
2022
36104566
Brain-restricted mTOR inhibition with binary pharmacology.
Nature
2022
36131014
Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
36131014
Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
35733514
Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma.
Neurooncol Adv
2022
35418219
Nuclear tetraspanin 8 promotes breast cancer progression.
Cell Res
2022
36446943
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
36446943
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
35915160
EGFR ligands dictate tumour suppression.
Nat Cell Biol
2022
36458436
Epigenetic Rewiring Underlies SMARCA4-Dependent Maintenance of Progenitor State in Pediatric H3K27M Diffuse Midline Glioma.
Cancer Discov
2022
35027753
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
Nat Med
2022
35090034
CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma.
Neuro Oncol
2022
35733514
Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma.
Neurooncol Adv
2022
35418219
Nuclear tetraspanin 8 promotes breast cancer progression.
Cell Res
2022
36446943
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
36446943
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
36458436
Epigenetic Rewiring Underlies SMARCA4-Dependent Maintenance of Progenitor State in Pediatric H3K27M Diffuse Midline Glioma.
Cancer Discov
2022
35972367
Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies.
CRISPR J
2022
36104566
Brain-restricted mTOR inhibition with binary pharmacology.
Nature
2022
36131014
Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
36131014
Failure of human rhombic lip differentiation underlies medulloblastoma formation.
Nature
2022
35915160
EGFR ligands dictate tumour suppression.
Nat Cell Biol
2022
36112789
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.
Cancer Res
2022
35090034
CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma.
Neuro Oncol
2022
34083417
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
J Immunother Cancer
2021
33909992
Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism.
Am J Hum Genet
2021
33585982
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).
Acta Neuropathol
2021
33741928
The transcriptional landscape of Shh medulloblastoma.
Nat Commun
2021
34107377
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.
Neoplasia
2021
33509943
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers.
Cancer Res
2021
34083417
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
J Immunother Cancer
2021
34409497
Subgroup and subtype-specific outcomes in adult medulloblastoma.
Acta Neuropathol
2021
34398189
A SHHecret target of relapsed medulloblastoma: Astrocytes.
J Exp Med
2021
34637499
All eyes on a phosphatase in glioma stem cells.
J Exp Med
2021
33909992
Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism.
Am J Hum Genet
2021
33741928
The transcriptional landscape of Shh medulloblastoma.
Nat Commun
2021
1 - 50 of 426
Column Actions
Search
Recommended Authors
David Pauck
German Cancer Research Center (DKFZ)
Career Start Year
2017
Number of shared co-authors
21
Sebastian Brabetz
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year
2016
Number of shared co-authors
64
Carl Koschmann
University of Michigan-Ann Arbor
Career Start Year
2010
Number of shared co-authors
36
Matthew D Wood
Oregon Health & Science University
Career Start Year
2007
Number of shared co-authors
23
Chitra Venugopal
McMaster Stem Cell and Cancer Research Institute
Career Start Year
2006
Number of shared co-authors
23
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year
2006
Number of shared co-authors
43
Anita B Hjelmeland
University of Alabama at Birmingham
Career Start Year
2004
Number of shared co-authors
8
Bo Hu
Northwestern University Feinberg School of Medicine
Career Start Year
2003
Number of shared co-authors
4
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year
2002
Number of shared co-authors
22
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year
2002
Number of shared co-authors
11
Sheila K Singh
McMaster University
Career Start Year
2001
Number of shared co-authors
54
Jeongwu Lee
Lerner Research Institute, Cleveland Clinic
Career Start Year
2001
Number of shared co-authors
9
Brent A Orr
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
71
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
9
Brian R Rood
Brain Tumor Institute, Children's National Hospital
Career Start Year
1998
Number of shared co-authors
57
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year
1996
Number of shared co-authors
8
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year
1996
Number of shared co-authors
39
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
9
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year
1995
Number of shared co-authors
30
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1994
Number of shared co-authors
33
Richard J Gilbertson
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year
1992
Number of shared co-authors
99
John Easton
St Jude Children's Research Hospital
Career Start Year
1991
Number of shared co-authors
31
Howard A Fine
Meyer Cancer Center
Career Start Year
1990
Number of shared co-authors
19
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Career Start Year
1990
Number of shared co-authors
15
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year
1990
Number of shared co-authors
65
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year
1989
Number of shared co-authors
23
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year
1989
Number of shared co-authors
52
Ching C Lau
Baylor College of Medicine
Career Start Year
1982
Number of shared co-authors
50
Charles Keller
Children's Cancer Therapy Development Institute
Career Start Year
1980
Number of shared co-authors
8
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Career Start Year
1974
Number of shared co-authors
41
row(s) 1 - 30 of 30
Collaborators
Michael D Taylor
The Hospital for Sick Children
Co-authored papers
33
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
25
Kevan M Shokat
University of California San Francisco
Co-authored papers
22
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers
21
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers
21
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers
20
Joanna J Phillips
University of California san francisco
Co-authored papers
18
Wies??awa Grajkowska
Children's Memorial Health Institute
Co-authored papers
18
Charles D James
Co-authored papers
18
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers
17
Livia Garzia
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers
17
Eric Bouffet
The Hospital for Sick Children
Co-authored papers
17
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
17
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
16
David J H Shih
University of Texas MD Anderson Cancer Center Houston
Co-authored papers
16
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers
16
Daphne A Haas-Kogan
Co-authored papers
16
Theodore Nicolaides
Co-authored papers
15
Anders I Persson
University of California san francisco
Co-authored papers
15
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
15
Seung-Ki Kim
Seoul National University Children's Hospital
Co-authored papers
15
Uri Tabori
Co-authored papers
15
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers
14
Ian F Pollack
University of Pittsburgh School of Medicine
Co-authored papers
14
Joshua B Rubin
Washington University in St. Louis
Co-authored papers
14
Boleslaw Lach
McMaster University
Co-authored papers
14
Luca Massimi
Co-authored papers
14
Nalin Gupta
Co-authored papers
14
Toshihiro Kumabe
Kitasato University School of Medicine
Co-authored papers
14
Pim J French
Erasmus MC Cancer Institute
Co-authored papers
14
1 - 30